Information Provided By: 
Fly News Breaks for August 3, 2016
CYH
Aug 3, 2016 | 10:30 EDT
As previously reported, UBS analyst A.J. Rice downgraded Community Health to Neutral from Buy after the company reported earnings that missed expectations, driven by higher than expected SW&B and supplies expenses. The turnaround at former HMA hospitals has proven "very elusive" and while applauding the company's efforts to reduce debt through asset sales, those efforts will also take time, said Rice, who cut his price target on the stock to $12.50 from $24.
News For CYH From the Last 2 Days
CYH
Apr 25, 2024 | 09:47 EDT
CYH
Apr 25, 2024 | 07:41 EDT
Oppenheimer lowered the firm's price target on Community Health to $4.50 from $5.50 and keeps an Outperform rating on the shares following quarterly results. The firm notes Community Health maintained its 2024 outlook. Overall, at these levels, Oppenheimer continues to see attractive upside for long-term investors.
